After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Regeneron Pharmaceuticals, Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Regeneron Pharmaceuticals, Inc is $76.56B. A total of 0.73 million shares were traded on the day, compared to an average of 895.69K shares.
In the most recent transaction, McCourt Marion sold 1,000 shares of REGN for 844.61 per share on Nov 01 ’24. After the transaction, the EVP Commercial now owns 12,931 company shares. In a previous transaction on Nov 01 ’24, MARION E MCCOURT bought 1,000 shares at 844.61 per share.
Among the insiders who sold shares, RYAN ARTHUR F disposed of 100 shares on Oct 01 ’24 at a per-share price of $1048.78. This resulted in the Director holding 17,582 shares of REGN after the transaction. In another insider transaction, McCourt Marion sold 1,000 shares at $1054.06 per share on Oct 01 ’24. Company shares held by the EVP Commercial now total 12,931.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. REGN’s most recent ex-dividend date was 0.53% when it declared a $0.88 quarterly dividend that was paid in cash on 2/20/2025.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, REGN has a high of $1211.20 and a low of $642.00.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. REGN’s latest balance sheet shows that the firm has $5.69B in Cash & Short Term Investments as of fiscal 2021. There were $2.70B in debt and $3.93B in liabilities at the time. Its Book Value Per Share was $267.82, while its Total Shareholder’s Equity was $18.77B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for REGN is Buy with a score of 4.46.
